Latest Stories
Walgreens (NASDAQ:WBA) Reports Upbeat Q4, Stock Soars
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.5% year on year to $39.46 billion. Its non-GAAP profit of $0.51 per share was 35.1% above analysts’ consensus estimates.
Tilray (NASDAQ:TLRY) Reports Sales Below Analyst Estimates In Q4 Earnings
Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year on year to $211 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 8.2% above analysts’ estimates. Its non-GAAP loss of $0 per share was $0.01 above analysts’ consensus estimates.
Delta Air Lines’s (NYSE:DAL) Q4 Sales Beat Estimates, Provides Optimistic Revenue Guidance for Next Quarter
Global airline Delta Air Lines (NYSE:DAL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 9.4% year on year to $15.56 billion. On top of that, next quarter’s revenue guidance ($14.85 billion at the midpoint) was surprisingly good and 12.7% above what analysts were expecting. Its GAAP profit of $1.29 per share was 27.4% below analysts’ consensus estimates.